Comparison Overview
High-Content Imaging | Molecular Devices
High-Content Imaging | Molecular Devices
N/A
Last Update: 25/03/2026
We empower researchers with cutting-edge AI-driven high-content screening solutions, delivering deeper insights into complex biological models. Our innovative ImageXpress® HCS.ai High-Content Screening System and IN Carta® Image Analysis Software streamline workflows fo...
Roche
Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH
Last Update: 28/06/2026
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...
Compliance Ranges Comparison
High-Content Imaging | Molecular Devices
Roche
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for High-Content Imaging | Molecular Devices in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Roche in 2026.
Incident History - High-Content Imaging | Molecular Devices (X = Date, Y = Severity)
High-Content Imaging | Molecular Devices cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Roche (X = Date, Y = Severity)
Roche cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
High-Content Imaging | Molecular Devices
Roche
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.